14.69
price up icon2.58%   0.37
after-market After Hours: 15.08 0.39 +2.65%
loading
Elanco Animal Health Inc stock is traded at $14.69, with a volume of 5.01M. It is up +2.58% in the last 24 hours and down -5.04% over the past month. Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands.
See More
Previous Close:
$14.32
Open:
$14.34
24h Volume:
5.01M
Relative Volume:
0.89
Market Cap:
$7.30B
Revenue:
$4.49B
Net Income/Loss:
$-1.26B
P/E Ratio:
-73.45
EPS:
-0.2
Net Cash Flow:
$425.00M
1W Performance:
+1.73%
1M Performance:
-5.04%
6M Performance:
-9.77%
1Y Performance:
+30.69%
1-Day Range:
Value
$14.33
$15.14
1-Week Range:
Value
$13.28
$15.14
52-Week Range:
Value
$8.52
$18.80

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
Name
Elanco Animal Health Inc
Name
Phone
877-352-6261
Name
Address
2500 INNOVATION WAY, GREENFIELD
Name
Employee
9,800
Name
Twitter
@Elanco
Name
Next Earnings Date
2024-08-08
Name
Latest SEC Filings
Name
ELAN's Discussions on Twitter

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-05-24 Upgrade Stifel Hold → Buy
Dec-19-23 Initiated Jefferies Buy
Dec-15-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-07-23 Initiated Exane BNP Paribas Outperform
Apr-20-23 Upgrade Barclays Equal Weight → Overweight
Aug-18-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-16-22 Downgrade JP Morgan Overweight → Neutral
Jul-21-22 Downgrade Goldman Buy → Sell
Jul-12-22 Initiated Piper Sandler Neutral
Nov-18-21 Initiated Morgan Stanley Overweight
Oct-28-21 Downgrade Stifel Buy → Hold
Aug-05-21 Resumed Credit Suisse Outperform
Jun-15-21 Upgrade Cleveland Research Underperform → Neutral
May-11-21 Upgrade Barclays Underweight → Equal Weight
May-11-21 Upgrade Gabelli & Co Hold → Buy
Apr-15-21 Initiated Stifel Buy
Mar-22-21 Downgrade Gabelli & Co Buy → Hold
Feb-26-21 Upgrade Credit Suisse Neutral → Outperform
Dec-09-20 Downgrade Argus Buy → Hold
Nov-09-20 Downgrade Barclays Overweight → Underweight
Aug-20-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-13-20 Resumed Credit Suisse Neutral
Aug-04-20 Resumed Goldman Buy
Jul-27-20 Downgrade Cleveland Research Neutral → Underperform
Apr-02-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-10-20 Initiated Raymond James Mkt Perform
Dec-19-19 Upgrade BofA/Merrill Neutral → Buy
Nov-07-19 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-23-19 Initiated Barclays Overweight
Aug-26-19 Downgrade BofA/Merrill Buy → Neutral
Aug-15-19 Upgrade UBS Sell → Neutral
May-23-19 Initiated Guggenheim Neutral
Mar-18-19 Upgrade BofA/Merrill Neutral → Buy
Mar-13-19 Resumed Morgan Stanley Equal-Weight
Feb-12-19 Initiated William Blair Mkt Perform
Jan-23-19 Initiated UBS Sell
Jan-15-19 Initiated Argus Buy
Oct-15-18 Initiated Morgan Stanley Equal-Weight
View All

Elanco Animal Health Inc Stock (ELAN) Latest News

pulisher
01:00 AM

Elanco Animal Health (NYSE:ELAN) Stock Price Up 5.4% - MarketBeat

01:00 AM
pulisher
03:37 AM

Amalgamated Bank Lowers Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

03:37 AM
pulisher
Sep 29, 2024

Clearline Capital LP Reduces Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Sep 29, 2024
pulisher
Sep 28, 2024

Lighthouse Investment Partners LLC Takes $2.56 Million Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Hurricane Helene highlights how important pets are to families: Jeff Simmons - Fox Business

Sep 27, 2024
pulisher
Sep 27, 2024

Elanco Animal Health Inc (ELAN) Trading 4.59% Higher on Sep 27 - GuruFocus.com

Sep 27, 2024
pulisher
Sep 27, 2024

Elanco Animal Health (NYSE:ELAN) Shares Gap Up to $13.73 - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Veterinary Biologics Global Market Report 2024: Size Forecast and Growth 2033 - WhaTech

Sep 26, 2024
pulisher
Sep 24, 2024

FDA Approves Greenfield Company’s Canine Itch Medicine - InkFreeNews.com

Sep 24, 2024
pulisher
Sep 24, 2024

Understanding ELAN’s financial ratios: A beginner’s guide - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

How Are Things Looking For Elanco Animal Health Inc (NYSE: ELAN) For The Short Term? - Stocks Register

Sep 24, 2024
pulisher
Sep 24, 2024

DA Davidson Reiterates "Buy" Rating for Estée Lauder Companies (NYSE:EL) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Elanco Animal Health Inc (ELAN) Stock: Navigating Drops and Gains - The InvestChronicle

Sep 24, 2024
pulisher
Sep 24, 2024

Lombard Odier Asset Management Europe Ltd Purchases Shares of 9,207 The Estée Lauder Companies Inc. (NYSE:EL) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Frank Rimerman Advisors LLC Acquires Shares of 40,813 Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

The Estée Lauder Companies Inc. (NYSE:EL) Shares Sold by Mutual of America Capital Management LLC - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Shapiro Capital Management LLC Has $137.86 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Elanco’s Zenrelia Receives FDA Approval - Today's Veterinary Business

Sep 23, 2024
pulisher
Sep 23, 2024

Magnetar Financial LLC Has $120.30 Million Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Elanco Animal Health (NYSE:ELAN) Price Target Raised to $22.00 at Barclays - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Davidson Kempner Capital Management LP Acquires New Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Elanco Animal Health Inc (ELAN) Becoming More Attractive for Investors - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Elanco's President & CEO on Zenrelia Approved by FDA - Marketscreener.com

Sep 23, 2024
pulisher
Sep 22, 2024

The Estée Lauder Companies Inc. (NYSE:EL) Shares Bought by Independent Franchise Partners LLP - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

64,822 Shares in Elanco Animal Health Incorporated (NYSE:ELAN) Acquired by XTX Topco Ltd - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Vanguard Personalized Indexing Management LLC Decreases Stock Position in The Estée Lauder Companies Inc. (NYSE:EL) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Oppenheimer Asset Management Inc. Boosts Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Canada Pension Plan Investment Board Takes $55.60 Million Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Sep 22, 2024
pulisher
Sep 21, 2024

Transatlantique Private Wealth LLC Sells 211 Shares of The Estée Lauder Companies Inc. (NYSE:EL) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by ASB Consultores LLC - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

The Estée Lauder Companies Inc. (NYSE:EL) Position Lowered by Amalgamated Bank - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Elanco Animal Health (NYSE:ELAN) Shares Gap Down to $14.65 - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Estée Lauder Companies (NYSE:EL) Downgraded by StockNews.com to Hold - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Ensign Peak Advisors Inc Sells 35,342 Shares of The Estée Lauder Companies Inc. (NYSE:EL) - MarketBeat

Sep 21, 2024
pulisher
Sep 21, 2024

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by Commonwealth Equity Services LLC - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Elanco Animal Health (NYSE:ELAN) Shares Down 3.5% - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Elanco’s dermatology treatment for itchy dogs gets FDA approval - Inside INdiana Business

Sep 20, 2024
pulisher
Sep 20, 2024

Elanco Animal Health Inc (ELAN) Trading Down 4.71% on Sep 20 - GuruFocus.com

Sep 20, 2024
pulisher
Sep 20, 2024

Elanco stock holds Neutral rating amid Zenrelia label review By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 20, 2024

Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy - Benzinga

Sep 20, 2024
pulisher
Sep 20, 2024

Elanco Animal Health (NYSE:ELAN) Rating Reiterated by Stifel Nicolaus - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Elanco Animal Health (NYSE:ELAN) Stock Rating Lowered by Morgan Stanley - MarketBeat

Sep 20, 2024
pulisher
Sep 19, 2024

Elanco’s dermatology treatment for itchy dogs gets FDA approval - Indianapolis Business Journal

Sep 19, 2024
pulisher
Sep 19, 2024

Demystifying Elanco Animal Health: Insights From 4 Analyst ReviewsElanco Animal Health (NYSE:ELAN) - Benzinga

Sep 19, 2024
pulisher
Sep 19, 2024

US FDA approves Elanco’s skin disease treatment for dogs - WSAU

Sep 19, 2024
pulisher
Sep 19, 2024

US FDA approves Elanco's skin disease treatment for dogs - Reuters

Sep 19, 2024
pulisher
Sep 19, 2024

US FDA approves Elanco's skin disease treatment for dogs - Yahoo Finance

Sep 19, 2024
pulisher
Sep 19, 2024

Carrier Global Co. (NYSE:CARR) Shares Sold by Elo Mutual Pension Insurance Co - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology - StockTitan

Sep 19, 2024
pulisher
Sep 19, 2024

Stifel maintains Buy rating on Elanco shares with no target price change - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

Elanco Animal Health (NYSE:ELAN) Shares Gap Down to $14.65 - MarketBeat

Sep 19, 2024

Elanco Animal Health Inc Stock (ELAN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$109.75
price up icon 2.23%
$73.17
price down icon 0.18%
$60.57
price up icon 0.40%
$115.22
price up icon 0.14%
drug_manufacturers_specialty_generic RDY
$79.45
price down icon 0.28%
$11.61
price up icon 0.52%
Cap:     |  Volume (24h):